Search - tctmd.com

Displaying 761 - 780 of 1565

Sort: Relevancy | Date

News Daily News

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

L.A. McKeown

October 15, 2019

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

Todd Neale

October 14, 2019

News Daily News

Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit

Shelley Wood

October 14, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Daily News

Any Troponin Bump in Suspected ACS—MI or Not—Signals High CV Risk: High-STEACS

Todd Neale

October 10, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Conference News TCT 2019

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Michael O'Riordan

October 03, 2019

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

Presentation TCT 2019

Equipment Entrapment/Loss: Prevention and Management

Presenter: Farouc Jaffer

September 28, 2019

Presentation TCT 2019

Donor Vessel Dissection and/or Thrombosis: How to Avoid, Recognize, and Manage

Presenter: M. Nicholas Burke

September 28, 2019

Presentation TCT 2019

Post-CABG Localized Tamponade: Prevention, Identification, and Management

Presenter: Robert Riley

September 28, 2019

Presentation TCT 2019

Septal Collateral Perforations: Prevention and Management

Presenter: Roberto Garbo

September 28, 2019

Presentation TCT 2019

Antegrade Wire or Device Exit at the CTO Site: Prevention and Management

Presenter: Nicholas Lembo

September 28, 2019

Presentation TCT 2019

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Presenter: Davide Capodanno

September 28, 2019

Presentation TCT 2019

Potential of NaF PET Imaging for Vulnerable Plaque and Patient Identification

Presenter: Bon-Kwon Koo

September 27, 2019

Presentation TCT 2019

Integration of Non-Invasive and Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Presenter: Ryan Madder

September 27, 2019

Presentation TCT 2019

Non-Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Presenter: James Min

September 27, 2019

Presentation TCT 2019

Utility of OCT-NIRF Molecular Imaging for Vulnerable Plaque Identification

Presenter: Farouc Jaffer

September 27, 2019

Presentation TCT 2019

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Presenter: Peter Stone

September 27, 2019

Advertisement

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

FDA Gives Rivaroxaban Another VTE-Related Indication

Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit

Recurrent Events Common Among Young Patients With CAD

Any Troponin Bump in Suspected ACS—MI or Not—Signals High CV Risk: High-STEACS

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Equipment Entrapment/Loss: Prevention and Management

Donor Vessel Dissection and/or Thrombosis: How to Avoid, Recognize, and Manage

Post-CABG Localized Tamponade: Prevention, Identification, and Management

Septal Collateral Perforations: Prevention and Management

Antegrade Wire or Device Exit at the CTO Site: Prevention and Management

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Potential of NaF PET Imaging for Vulnerable Plaque and Patient Identification

Integration of Non-Invasive and Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Non-Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Utility of OCT-NIRF Molecular Imaging for Vulnerable Plaque Identification

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content